Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Hamostaseologie|December 5, 2018
Thromboinflammation and Vascular DysfunctionSusanne Karbach, Jérémy Lagrange, Philip WenzelCurrent Pharmaceutical Design|November 5, 2013
eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammationSusanne Karbach, Philip Wenzel, Ari Waisman, et al.American Journal of Hypertension|September 15, 2020
Innate Immune Mechanisms of Arterial Hypertension and Autoimmune DiseaseRebecca Jung, Johannes Wild, Julia Ringen, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 3, 2020
Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide)Wen Chen, Franziska Werner, Anja Illerhaus, et al.Journal of Clinical Medicine|September 22, 2020
Psoriasis and Its Impact on In-Hospital Outcome in Patients Hospitalized with Acute Kidney InjuryJohannes Wild, Lukas Hobohm, Thomas Münzel, et al.Biofactors (Oxford, England)|May 4, 2023
Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammationTheresa Schaller, Julia Ringen, Berenice Fischer, et al.Heliyon|November 28, 2022
B lymphocyte-deficiency in mice promotes venous thrombosisSolveig Hasselwander, Ning Xia, Maximilian Mimmler, et al.Scientific Reports|February 16, 2018
Lack of T-bet reduces monocytic interleukin-12 formation and accelerates thrombus resolution in deep vein thrombosisTanja Schönfelder, Moritz Brandt, Sabine Kossmann, et al.Journal of the American Heart Association|September 11, 2020
Impact of Psoriasis on Mortality Rate and Outcome in Myocardial InfarctionSusanne Karbach, Lukas Hobohm, Johannes Wild, et al.International Journal of Molecular Sciences|September 5, 2019
Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and InflammationJohannes Wild, Rebecca Schüler, Tanja Knopp, et al.Pageof 20